Webinar: Addressing pandemics through cellular virology
In the context of the whole person, cellular virology provides a framework for understanding disease infection and transmission to inform prevention practices and the development of treatments. Research during the AIDS epidemic generated foundational knowledge and strategic maps to address disease caused by viral infection and transmission. These lessons offer guidance for approaching the COVID-19 pandemic by characterizing the cell biology of SARS-CoV2 within cellular models, organoid models, disease models, and ultimately humans.
Join this webinar to learn how Dr. Thomas Hope’s study of virology went from first seeing a virus move in a cell to understanding infection in context of the organism, leading to a global network of researchers providing resources necessary to improve human health. We will chronicle Dr. Hope’s extensive achievements in the area of HIV, from preliminary studies in the San Francisco Bay area to his pioneering cellular virology work at the Salk Institute early in the AIDS epidemic. After attending the 2020Emerging Infectious Diseases (EID) in the Pacific Rimconference in Bangkok, Dr. Hope raced home to pivot his research efforts toward SARS-CoV2 just as the COVID-19 pandemic began sweeping the globe.
Discussion Topics:
• Pandemics past and present —understanding history to shape the future
• Technology and science coevolve to advance our understanding
• What scientific and public health approaches have been promoted, and what strategies need to be pushed
Speakers:
Thomas J. Hope Phd,
Professor Department of Cell and Developmental Biology
Northwestern University
Thomas J. Hope, PhD is a professor in the Department of Cell and Developmental Biology and Obstetrics and Gynecology in the Feinberg School of Medicine and in Biomedical Engineering in the McCormick School of Engineering and Applied Sciences at Northwestern University.
Dr. Hope’s laboratory has been a pioneer in the use of cell biology approaches to study HIV, providing images and movies of HIV interacting with cells and tissues. For the past 30 years, his research has focused on HIV cellular virology and has grown to HIV-related mucosal immunology, HIV transmission, and HIV prevention science. Dr. Hope has provided unique insight into the space and time of the earliest events of HIV transmission and infection by using a series of imaging-based tools to define key viral and host players in the physiologically relevant context of live animal and human tissue anatomy and physiology. In light of the COVID-19 pandemic, he is applying this wholistic approach of cellular virology in context, learned from studying HIV, to SARS-CoV2 transmission and prevention to inform strategies to stem the pandemic.
Dr. Hope is co-chair of the AIDS Panel: U.S.-Japan Cooperative Medical Science Program and he is on the organizing committee for Emerging Infectious Diseases in the Pacific Rim. His editorial service includes: section editor, PloS Pathogens; editor in chief, AIDS Research and Human Retroviruses; and editorial board member of the Journal of Virology. Dr. Hope is also a member of the amfAR Scientific Advisory Committee.
Rick Heil-Chapdelaine Phd,
Business Development, Cell Analysis
Cytiva
Since tromping through woods as a child, Rick Heil-Chapdelaine has been turning over rocks to discover the hidden. His curiosity continued at the University of Minnesota, studying Genetics and Cell Biology, and further in his PhD studies at Purdue University in Cell and Developmental Biology. He grew his use of microscopy at Washington University School of Medicine integrating genetics, molecular biology, and biochemistry to reveal mechanisms involved in mitotic spindle positioning and cell cycle control —first as a post doc and then as an assistant professor, publishing first and last author papers and reviews. He has spent the last decade and a half helping researchers configure microscope systems and navigate which mode of microscopy best meets their research goals —from widefield fluorescence, confocal and multiphoton, to super resolution and high content analysis —all while guiding them to get the most from their technologies.
Ian Kirk
Business Development, Cell Analysis
Cytiva
Ian Kirk leads microscopy sales and scientific teams for Cytiva in the United States and Canada. He entered the life sciences by spearheading imaging divisions at two microscope dealers in the US as the field of microscopy was transitioning from photo microscopy to digital microscopy and analysis. He then honed business strategies and refined group dynamics with the technical marketing group at Olympus, coordinating and conducting team trainings and customer demonstrations of complex integrated live cell imaging systems. Ian’s thirst to develop people and build teams has driven him to understand and work across the breadth of life sciences at Cytiva —from academic discovery to biomanufacturing and pharma.